<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-04-27" modified="2017-05-10" version="177">
<accession>Q92630</accession>
<accession>B2R9V9</accession>
<accession>Q9BRB5</accession>
<name>DYRK2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Dual specificity tyrosine-phosphorylation-regulated kinase 2</fullName>
<ecNumber>2.7.12.1</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">DYRK2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="25893" last="25902">
<title>Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases.</title>
<authorList>
<person name="Becker W."/>
<person name="Weber Y."/>
<person name="Wetzel K."/>
<person name="Eirmbter K."/>
<person name="Tejedor F.J."/>
<person name="Joost H.-G."/>
</authorList>
<dbReference type="PubMed" id="9748265"/>
<dbReference type="DOI" id="10.1074/jbc.273.40.25893"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>COFACTOR</scope>
<scope>PHOSPHORYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Muscle</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="1996-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Becker W."/>
<person name="Joost H.-G."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 320-528 (ISOFORMS 1/2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Biochem. J." volume="355" first="609" last="615">
<title>The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.</title>
<authorList>
<person name="Woods Y.L."/>
<person name="Cohen P."/>
<person name="Becker W."/>
<person name="Jakes R."/>
<person name="Goedert M."/>
<person name="Wang X."/>
<person name="Proud C.G."/>
</authorList>
<dbReference type="PubMed" id="11311121"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="4136" last="4143">
<title>Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.</title>
<authorList>
<person name="Miller C.T."/>
<person name="Aggarwal S."/>
<person name="Lin T.K."/>
<person name="Dagenais S.L."/>
<person name="Contreras J.I."/>
<person name="Orringer M.B."/>
<person name="Glover T.W."/>
<person name="Beer D.G."/>
<person name="Lin L."/>
</authorList>
<dbReference type="PubMed" id="12874018"/>
</citation>
<scope>INDUCTION IN CANCER</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="1546" last="1557">
<title>The C terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation.</title>
<authorList>
<person name="Wang X."/>
<person name="Li W."/>
<person name="Parra J.L."/>
<person name="Beugnet A."/>
<person name="Proud C.G."/>
</authorList>
<dbReference type="PubMed" id="12588975"/>
<dbReference type="DOI" id="10.1128/MCB.23.5.1546-1557.2003"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="2490" last="2498">
<title>Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family protein kinases.</title>
<authorList>
<person name="Skurat A.V."/>
<person name="Dietrich A.D."/>
</authorList>
<dbReference type="PubMed" id="14593110"/>
<dbReference type="DOI" id="10.1074/jbc.M301769200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="4612" last="4624">
<title>Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors.</title>
<authorList>
<person name="de Graaf K."/>
<person name="Hekerman P."/>
<person name="Spelten O."/>
<person name="Herrmann A."/>
<person name="Packman L.C."/>
<person name="Bussow K."/>
<person name="Muller-Newen G."/>
<person name="Becker W."/>
</authorList>
<dbReference type="PubMed" id="14623875"/>
<dbReference type="DOI" id="10.1074/jbc.M310794200"/>
</citation>
<scope>INTERACTION WITH CCNL2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Biochem. J." volume="389" first="775" last="783">
<title>Identification of calcium-regulated heat-stable protein of 24 kDa (CRHSP24) as a physiological substrate for PKB and RSK using KESTREL.</title>
<authorList>
<person name="Auld G.C."/>
<person name="Campbell D.G."/>
<person name="Morrice N."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="15910284"/>
<dbReference type="DOI" id="10.1042/BJ20050733"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="16591" last="16598">
<title>Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo.</title>
<authorList>
<person name="Cole A.R."/>
<person name="Causeret F."/>
<person name="Yadirgi G."/>
<person name="Hastie C.J."/>
<person name="McLauchlan H."/>
<person name="McManus E.J."/>
<person name="Hernandez F."/>
<person name="Eickholt B.J."/>
<person name="Nikolic M."/>
<person name="Sutherland C."/>
</authorList>
<dbReference type="PubMed" id="16611631"/>
<dbReference type="DOI" id="10.1074/jbc.M513344200"/>
</citation>
<scope>FUNCTION AS CRMP4/DPYSL3 KINASE</scope>
<scope>ENZYME REGULATION BY PURVALANOL</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Nature" volume="441" first="646" last="650">
<title>A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT.</title>
<authorList>
<person name="Gwack Y."/>
<person name="Sharma S."/>
<person name="Nardone J."/>
<person name="Tanasa B."/>
<person name="Iuga A."/>
<person name="Srikanth S."/>
<person name="Okamura H."/>
<person name="Bolton D."/>
<person name="Feske S."/>
<person name="Hogan P.G."/>
<person name="Rao A."/>
</authorList>
<dbReference type="PubMed" id="16511445"/>
<dbReference type="DOI" id="10.1038/nature04631"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NFATC1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="Mol. Cell" volume="25" first="725" last="738">
<title>DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage.</title>
<authorList>
<person name="Taira N."/>
<person name="Nihira K."/>
<person name="Yamaguchi T."/>
<person name="Miki Y."/>
<person name="Yoshida K."/>
</authorList>
<dbReference type="PubMed" id="17349958"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.02.007"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Biochem. Pharmacol." volume="76" first="1389" last="1394">
<title>Role for DYRK family kinases on regulation of apoptosis.</title>
<authorList>
<person name="Yoshida K."/>
</authorList>
<dbReference type="PubMed" id="18599021"/>
<dbReference type="DOI" id="10.1016/j.bcp.2008.05.021"/>
</citation>
<scope>FUNCTION IN APOPTOSIS AS P53/TP53 KINASE</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION BY ATM</scope>
<scope>GENE FAMILY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Cell" volume="133" first="537" last="548">
<title>Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling.</title>
<authorList>
<person name="Varjosalo M."/>
<person name="Bjorklund M."/>
<person name="Cheng F."/>
<person name="Syvanen H."/>
<person name="Kivioja T."/>
<person name="Kilpinen S."/>
<person name="Sun Z."/>
<person name="Kallioniemi O."/>
<person name="Stunnenberg H.G."/>
<person name="He W.W."/>
<person name="Ojala P."/>
<person name="Taipale J."/>
</authorList>
<dbReference type="PubMed" id="18455992"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.02.047"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT THR-381 AND SER-449</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Trends Mol. Med." volume="14" first="305" last="313">
<title>Nuclear trafficking of pro-apoptotic kinases in response to DNA damage.</title>
<authorList>
<person name="Yoshida K."/>
</authorList>
<dbReference type="PubMed" id="18539531"/>
<dbReference type="DOI" id="10.1016/j.molmed.2008.05.003"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="FEBS J." volume="276" first="6324" last="6337">
<title>Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation.</title>
<authorList>
<person name="Goeckler N."/>
<person name="Jofre G."/>
<person name="Papadopoulos C."/>
<person name="Soppa U."/>
<person name="Tejedor F.J."/>
<person name="Becker W."/>
</authorList>
<dbReference type="PubMed" id="19796173"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2009.07346.x"/>
</citation>
<scope>ENZYME REGULATION BY HARMINE</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Nat. Cell Biol." volume="11" first="409" last="419">
<title>Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase.</title>
<authorList>
<person name="Maddika S."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19287380"/>
<dbReference type="DOI" id="10.1038/ncb1848"/>
</citation>
<scope>FUNCTION IN E3 LIGASE REGULATION</scope>
<scope>FUNCTION AS KATNA1 KINASE</scope>
<scope>INTERACTION WITH EDVP COMPLEX</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Bioorg. Med. Chem. Lett." volume="20" first="3491" last="3494">
<title>Structure-activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors.</title>
<authorList>
<person name="Cuny G.D."/>
<person name="Robin M."/>
<person name="Ulyanova N.P."/>
<person name="Patnaik D."/>
<person name="Pique V."/>
<person name="Casano G."/>
<person name="Liu J.-F."/>
<person name="Lin X."/>
<person name="Xian J."/>
<person name="Glicksman M.A."/>
<person name="Stein R.L."/>
<person name="Higgins J.M.G."/>
</authorList>
<dbReference type="PubMed" id="20836251"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2010.04.150"/>
</citation>
<scope>ENZYME REGULATION BY ACRIDINE ANALOGS</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="4909" last="4919">
<title>ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage.</title>
<authorList>
<person name="Taira N."/>
<person name="Yamamoto H."/>
<person name="Yamaguchi T."/>
<person name="Miki Y."/>
<person name="Yoshida K."/>
</authorList>
<dbReference type="PubMed" id="19965871"/>
<dbReference type="DOI" id="10.1074/jbc.M109.042341"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT THR-106 AND SER-442 BY ATM</scope>
<scope>UBIQUITINATION BY MDM2</scope>
<scope>INTERACTION WITH MDM2</scope>
<scope>MUTAGENESIS OF THR-106; SER-442 AND 189-LYS--ARG-191</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>INDUCTION BY DNA DAMAGE</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2012" name="J. Clin. Invest." volume="122" first="859" last="872">
<title>DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.</title>
<authorList>
<person name="Taira N."/>
<person name="Mimoto R."/>
<person name="Kurata M."/>
<person name="Yamaguchi T."/>
<person name="Kitagawa M."/>
<person name="Miki Y."/>
<person name="Yoshida K."/>
</authorList>
<dbReference type="PubMed" id="22307329"/>
<dbReference type="DOI" id="10.1172/JCI60818"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="J. Mol. Cell Biol." volume="4" first="316" last="330">
<title>Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways.</title>
<authorList>
<person name="Perez M."/>
<person name="Garcia-Limones C."/>
<person name="Zapico I."/>
<person name="Marina A."/>
<person name="Schmitz M.L."/>
<person name="Munoz E."/>
<person name="Calzado M.A."/>
</authorList>
<dbReference type="PubMed" id="22878263"/>
<dbReference type="DOI" id="10.1093/jmcb/mjs047"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION BY SIAH2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="7252" last="7262">
<title>Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation.</title>
<authorList>
<person name="Jung H.Y."/>
<person name="Wang X."/>
<person name="Jun S."/>
<person name="Park J.I."/>
</authorList>
<dbReference type="PubMed" id="23362280"/>
<dbReference type="DOI" id="10.1074/jbc.M112.416792"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-251</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="submission" date="2010-01" db="PDB data bank">
<title>Crystal structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (DYRK2) in complex with an indirubin ligand.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 146-552 IN COMPLEX WITH INDIRUBIN</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="J. Med. Chem." volume="55" first="9312" last="9330">
<title>Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B.</title>
<authorList>
<person name="Tahtouh T."/>
<person name="Elkins J.M."/>
<person name="Filippakopoulos P."/>
<person name="Soundararajan M."/>
<person name="Burgy G."/>
<person name="Durieu E."/>
<person name="Cochet C."/>
<person name="Schmid R.S."/>
<person name="Lo D.C."/>
<person name="Delhommel F."/>
<person name="Oberholzer A.E."/>
<person name="Pearl L.H."/>
<person name="Carreaux F."/>
<person name="Bazureau J.P."/>
<person name="Knapp S."/>
<person name="Meijer L."/>
</authorList>
<dbReference type="PubMed" id="22998443"/>
<dbReference type="DOI" id="10.1021/jm301034u"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 146-540 IN COMPLEX WITH LEUCETTAMINE DERIVATIVE</scope>
<scope>PHOSPHORYLATION AT TYR-382</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>ENZYME REGULATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="Structure" volume="21" first="986" last="996">
<title>Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.</title>
<authorList>
<person name="Soundararajan M."/>
<person name="Roos A.K."/>
<person name="Savitsky P."/>
<person name="Filippakopoulos P."/>
<person name="Kettenbach A.N."/>
<person name="Olsen J.V."/>
<person name="Gerber S.A."/>
<person name="Eswaran J."/>
<person name="Knapp S."/>
<person name="Elkins J.M."/>
</authorList>
<dbReference type="PubMed" id="23665168"/>
<dbReference type="DOI" id="10.1016/j.str.2013.03.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.36 ANGSTROMS) OF 146-552</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] GLY-98; LEU-198; ASN-245; SER-295; GLN-451 AND TYR-455</scope>
</reference>
<comment type="function">
<text evidence="7 8 10 12 13 14 16 17 18 19 23 24 26 27">Serine/threonine-protein kinase involved in the regulation of the mitotic cell cycle, cell proliferation, apoptosis, organization of the cytoskeleton and neurite outgrowth. Functions in part via its role in ubiquitin-dependent proteasomal protein degradation. Functions downstream of ATM and phosphorylates p53/TP53 at 'Ser-46', and thereby contributes to the induction of apoptosis in response to DNA damage. Phosphorylates NFATC1, and thereby inhibits its accumulation in the nucleus and its transcription factor activity. Phosphorylates EIF2B5 at 'Ser-544', enabling its subsequent phosphorylation and inhibition by GSK3B. Likewise, phosphorylation of NFATC1, CRMP2/DPYSL2 and CRMP4/DPYSL3 promotes their subsequent phosphorylation by GSK3B. May play a general role in the priming of GSK3 substrates. Inactivates GYS1 by phosphorylation at 'Ser-641', and potentially also a second phosphorylation site, thus regulating glycogen synthesis. Mediates EDVP E3 ligase complex formation and is required for the phosphorylation and subsequent degradation of KATNA1. Phosphorylates TERT at 'Ser-457', promoting TERT ubiquitination by the EDVP complex. Phosphorylates SIAH2, and thereby increases its ubiquitin ligase activity. Promotes the proteasomal degradation of MYC and JUN, and thereby regulates progress through the mitotic cell cycle and cell proliferation. Promotes proteasomal degradation of GLI2 and GLI3, and thereby plays a role in smoothened and sonic hedgehog signaling. Plays a role in cytoskeleton organization and neurite outgrowth via its phosphorylation of DCX and DPYSL2. Phosphorylates CRMP2/DPYSL2, CRMP4/DPYSL3, DCX, EIF2B5, EIF4EBP1, GLI2, GLI3, GYS1, JUN, MDM2, MYC, NFATC1, p53/TP53, TAU/MAPT and KATNA1. Can phosphorylate histone H1, histone H3 and histone H2B (in vitro). Can phosphorylate CARHSP1 (in vitro).</text>
</comment>
<comment type="catalytic activity">
<text evidence="25">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="27">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="cofactor">
<cofactor evidence="27">
<name>Mn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29035"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="14 20 22 25">Activated by autophosphorylation on the second tyrosine residue in the Tyr-X-Tyr motif in the activation loop. Inhibited by acridine analogs, purvalanol, and barely by harmine. Inhibited by leucettine and leucettine derivatives.</text>
</comment>
<comment type="subunit">
<text evidence="11 13 19 21 25 28">Component of an E3 ligase complex containing DYRK2, EDD/UBR5, DDB1 and DCAF1 (EDVP complex). Interacts directly with EDD/UBR5, DDB1 and DCAF1. Interacts with SIAH2 and MDM2. Interacts with MAP3K10 and NFATC1. May also interact with CCNL2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749432"/>
<interactant intactId="EBI-3914009">
<id>Q9NR20</id>
<label>DYRK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749432"/>
<interactant intactId="EBI-745305">
<id>Q13422</id>
<label>IKZF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749432"/>
<interactant intactId="EBI-739657">
<id>Q9BQD3</id>
<label>KXD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749432"/>
<interactant intactId="EBI-741037">
<id>Q9BRK4</id>
<label>LZTS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749432"/>
<interactant intactId="EBI-751145">
<id>P23497</id>
<label>SP100</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749432"/>
<interactant intactId="EBI-714790">
<id>O43379</id>
<label>WDR62</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749432"/>
<interactant intactId="EBI-395708">
<id>Q96C00</id>
<label>ZBTB9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Translocates into the nucleus following DNA damage.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q92630-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q92630-2</id>
<name>2</name>
<sequence type="described" ref="VSP_026115"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="27">Testis, after the onset of spermatogenesis.</text>
</comment>
<comment type="induction">
<text evidence="9 21">Accumulates in nucleus upon DNA damage. Induced in both esophageal and lung adenocarcinomas.</text>
</comment>
<comment type="PTM">
<text evidence="21">Autophosphorylates cotranslationally on the second tyrosine residue in the Tyr-X-Tyr motif in the activation loop, but once mature, does not have any protein tyrosine kinase activity. Phosphorylated at Thr-106 and Ser-442 by ATM in response to genotoxic stress.</text>
</comment>
<comment type="PTM">
<text evidence="21 24">Under normal conditions, polyubiquitinated in the nucleus by MDM2, leading to its proteasomal degradation. Phosphorylation on Thr-106 and Ser-442 by ATM in response to genotoxic stress disrupts MDM2 binding and prevents MDM2-mediated ubiquitination and subsequent proteasomal degradation. Polyubiquitinated by SIAH2, leading to its proteasomal degradation. Polyubiquitinated by SIAH2 occurs under normal conditions, and is enhanced in response to hypoxia.</text>
</comment>
<comment type="similarity">
<text evidence="30">Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MNB/DYRK subfamily.</text>
</comment>
<comment type="sequence caution" evidence="30">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA73885" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<dbReference type="EC" id="2.7.12.1"/>
<dbReference type="EMBL" id="Y13493">
<property type="protein sequence ID" value="CAA73885.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313937">
<property type="protein sequence ID" value="BAG36656.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471054">
<property type="protein sequence ID" value="EAW97176.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC005809">
<property type="protein sequence ID" value="AAH05809.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC006375">
<property type="protein sequence ID" value="AAH06375.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y09216">
<property type="protein sequence ID" value="CAA70418.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8978.1">
<molecule id="Q92630-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8979.1">
<molecule id="Q92630-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003574.1">
<molecule id="Q92630-2"/>
<property type="nucleotide sequence ID" value="NM_003583.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006473.2">
<molecule id="Q92630-1"/>
<property type="nucleotide sequence ID" value="NM_006482.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016875521.1">
<molecule id="Q92630-2"/>
<property type="nucleotide sequence ID" value="XM_017020032.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.173135"/>
<dbReference type="PDB" id="3K2L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.36"/>
<property type="chains" value="A=146-552"/>
</dbReference>
<dbReference type="PDB" id="3KVW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.28"/>
<property type="chains" value="A=146-552"/>
</dbReference>
<dbReference type="PDB" id="4AZF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=146-540"/>
</dbReference>
<dbReference type="PDB" id="5LXC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B=146-552"/>
</dbReference>
<dbReference type="PDB" id="5LXD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B=146-552"/>
</dbReference>
<dbReference type="PDBsum" id="3K2L"/>
<dbReference type="PDBsum" id="3KVW"/>
<dbReference type="PDBsum" id="4AZF"/>
<dbReference type="PDBsum" id="5LXC"/>
<dbReference type="PDBsum" id="5LXD"/>
<dbReference type="ProteinModelPortal" id="Q92630"/>
<dbReference type="SMR" id="Q92630"/>
<dbReference type="BioGrid" id="114023">
<property type="interactions" value="51"/>
</dbReference>
<dbReference type="IntAct" id="Q92630">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="MINT" id="MINT-1469581"/>
<dbReference type="STRING" id="9606.ENSP00000342105"/>
<dbReference type="BindingDB" id="Q92630"/>
<dbReference type="ChEMBL" id="CHEMBL4376"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2011"/>
<dbReference type="iPTMnet" id="Q92630"/>
<dbReference type="PhosphoSitePlus" id="Q92630"/>
<dbReference type="BioMuta" id="DYRK2"/>
<dbReference type="DMDM" id="148887370"/>
<dbReference type="EPD" id="Q92630"/>
<dbReference type="MaxQB" id="Q92630"/>
<dbReference type="PaxDb" id="Q92630"/>
<dbReference type="PeptideAtlas" id="Q92630"/>
<dbReference type="PRIDE" id="Q92630"/>
<dbReference type="DNASU" id="8445"/>
<dbReference type="Ensembl" id="ENST00000344096">
<molecule id="Q92630-1"/>
<property type="protein sequence ID" value="ENSP00000342105"/>
<property type="gene ID" value="ENSG00000127334"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393555">
<molecule id="Q92630-2"/>
<property type="protein sequence ID" value="ENSP00000377186"/>
<property type="gene ID" value="ENSG00000127334"/>
</dbReference>
<dbReference type="GeneID" id="8445"/>
<dbReference type="KEGG" id="hsa:8445"/>
<dbReference type="UCSC" id="uc001str.5">
<molecule id="Q92630-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8445"/>
<dbReference type="DisGeNET" id="8445"/>
<dbReference type="GeneCards" id="DYRK2"/>
<dbReference type="HGNC" id="HGNC:3093">
<property type="gene designation" value="DYRK2"/>
</dbReference>
<dbReference type="HPA" id="HPA027230"/>
<dbReference type="HPA" id="HPA056902"/>
<dbReference type="MIM" id="603496">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92630"/>
<dbReference type="OpenTargets" id="ENSG00000127334"/>
<dbReference type="PharmGKB" id="PA27550"/>
<dbReference type="eggNOG" id="KOG0667">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XPET">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119032"/>
<dbReference type="HOGENOM" id="HOG000220863"/>
<dbReference type="HOVERGEN" id="HBG051426"/>
<dbReference type="InParanoid" id="Q92630"/>
<dbReference type="KO" id="K18669"/>
<dbReference type="OMA" id="KLTTFEH"/>
<dbReference type="OrthoDB" id="EOG091G0Q46"/>
<dbReference type="PhylomeDB" id="Q92630"/>
<dbReference type="TreeFam" id="TF314624"/>
<dbReference type="BRENDA" id="2.7.12.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="SignaLink" id="Q92630"/>
<dbReference type="SIGNOR" id="Q92630"/>
<dbReference type="ChiTaRS" id="DYRK2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q92630"/>
<dbReference type="GeneWiki" id="DYRK2"/>
<dbReference type="GenomeRNAi" id="8445"/>
<dbReference type="PRO" id="PR:Q92630"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000127334"/>
<dbReference type="CleanEx" id="HS_DYRK2"/>
<dbReference type="ExpressionAtlas" id="Q92630">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92630">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0030529">
<property type="term" value="C:intracellular ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000151">
<property type="term" value="C:ubiquitin ligase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030145">
<property type="term" value="F:manganese ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004712">
<property type="term" value="F:protein serine/threonine/tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043130">
<property type="term" value="F:ubiquitin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051534">
<property type="term" value="P:negative regulation of NFAT protein import into nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045725">
<property type="term" value="P:positive regulation of glycogen biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007224">
<property type="term" value="P:smoothened signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0464">Manganese</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<feature type="chain" description="Dual specificity tyrosine-phosphorylation-regulated kinase 2" id="PRO_0000085936">
<location>
<begin position="1"/>
<end position="601"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="5">
<location>
<begin position="222"/>
<end position="535"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="30">
<location>
<begin position="228"/>
<end position="236"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="30">
<location>
<begin position="301"/>
<end position="304"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="31">
<location>
<begin position="189"/>
<end position="191"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="5 6">
<location>
<position position="348"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="30">
<location>
<position position="251"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="30"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by ATM" evidence="21">
<location>
<position position="106"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAP3K10" evidence="17">
<location>
<position position="381"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="25">
<location>
<position position="382"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM" evidence="21">
<location>
<position position="442"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAP3K10" evidence="17">
<location>
<position position="449"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_026115" evidence="29">
<location>
<begin position="1"/>
<end position="73"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35139851." id="VAR_040458" evidence="15">
<original>S</original>
<variation>G</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In a glioblastoma multiforme sample; somatic mutation." id="VAR_040459" evidence="15">
<original>P</original>
<variation>L</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34166200." id="VAR_040460" evidence="15">
<original>H</original>
<variation>N</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56293072." id="VAR_040461" evidence="15">
<original>N</original>
<variation>S</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35688869." id="VAR_040462" evidence="15">
<original>R</original>
<variation>Q</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55774594." id="VAR_040463" evidence="15">
<original>F</original>
<variation>Y</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired ATM-mediated phosphorylation, reduced affinity with MDM2 and altered MDM2-triggered ubiquitination." evidence="21">
<original>T</original>
<variation>A</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired nuclear translocation." evidence="21">
<original>KKR</original>
<variation>NNN</variation>
<location>
<begin position="189"/>
<end position="191"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes protein serine/threonine kinase activity." evidence="26">
<original>K</original>
<variation>R</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired ATM-mediated phosphorylation, reduced affinity with MDM2 and altered MDM2-triggered ubiquitination." evidence="21">
<original>S</original>
<variation>A</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA73885." ref="1" evidence="30">
<original>A</original>
<variation>P</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="149"/>
<end position="152"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="156"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="164"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="169"/>
<end position="174"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="198"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="206"/>
<end position="208"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="219"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="222"/>
<end position="231"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="234"/>
<end position="241"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="242"/>
<end position="245"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="246"/>
<end position="253"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="257"/>
<end position="274"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="287"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="297"/>
<end position="301"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="308"/>
<end position="314"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="315"/>
<end position="317"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="322"/>
<end position="341"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="351"/>
<end position="353"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="354"/>
<end position="358"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="364"/>
<end position="366"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="375"/>
<end position="377"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="386"/>
<end position="388"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="391"/>
<end position="395"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="402"/>
<end position="417"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="427"/>
<end position="438"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="443"/>
<end position="447"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="452"/>
<end position="455"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="465"/>
<end position="469"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="471"/>
<end position="473"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="475"/>
<end position="478"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="496"/>
<end position="499"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="500"/>
<end position="502"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="506"/>
<end position="515"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="520"/>
<end position="522"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="526"/>
<end position="529"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="533"/>
<end position="535"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3K2L"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KVW"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5LXC"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11311121"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12588975"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12874018"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14593110"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14623875"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15910284"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16511445"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16611631"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17349958"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18455992"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18599021"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19287380"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19796173"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19965871"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20836251"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22307329"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22878263"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22998443"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23362280"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9748265"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source ref="26"/>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<evidence key="31" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19965871"/>
</source>
</evidence>
<sequence length="601" mass="66652" checksum="A7BEE25CDF944436" modified="2007-06-12" version="3">
MLTRKPSAAAPAAYPTGRGGDSAVRQLQASPGLGAGATRSGVGTGPPSPIALPPLRASNA
AAAAHTIGGSKHTMNDHLHVGSHAHGQIQVQQLFEDNSNKRTVLTTQPNGLTTVGKTGLP
VVPERQLDSIHRRQGSSTSLKSMEGMGKVKATPMTPEQAMKQYMQKLTAFEHHEIFSYPE
IYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAY
DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT
FELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG
RSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP
LLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGG
RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP
KPPTGEKTSVKRITESTGAITSISKLPPPSSSASKLRTNLAQMTDANGNIQQRTVLPKLV
S
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>